Sleep Duration Reveals U-Shaped Risk for Accelerated Biological Ageing

By VirentaNews Staff — May 21, 2026

Emerging evidence indicates that both insufficient and excessive sleep are associated with accelerated biological ageing across multiple organ systems, according to a comprehensive multimodal analysis published in Nature. The study reveals a pronounced U-shaped relationship between sleep duration and markers of physiological decline, suggesting that deviations from optimal sleep—defined as seven hours per night—are linked to systemic ageing. Critically, the research also demonstrates that these biological changes partially mediate the increased risk of late-life depression observed in individuals with extreme sleep patterns, offering a mechanistic explanation for long-observed epidemiological trends.

Biological Ageing Across Organ Systems

The study analyzed data from over 85,000 adults in the UK Biobank, using epigenetic clocks, organ-specific biomarkers, and neuroimaging to assess biological age across nine physiological systems—including the liver, kidneys, heart, lungs, and brain. Participants who reported sleeping less than six hours or more than nine hours per night exhibited significantly accelerated biological ageing compared to those with seven-hour sleep durations. For instance, short sleepers showed a 2.6-year increase in liver age and a 2.1-year increase in brain age, while long sleepers demonstrated a 3.1-year advance in heart age and a 2.8-year increase in vascular age. These effects persisted after adjusting for confounders such as BMI, physical activity, smoking, and pre-existing disease. The multimodal assessment allowed researchers to confirm that sleep extremes affect multiple organ systems simultaneously, suggesting a systemic rather than isolated impact on physiological integrity.

Key Researchers and Institutional Roles

The research was led by a team from the University of Cambridge and the Max Planck Institute for Human Cognitive and Brain Sciences, leveraging machine learning models to integrate multi-omic data with behavioral and clinical metrics. Senior author Dr. Xiaojie Wang emphasized the importance of using biological age as a more sensitive indicator of health decline than chronological age alone. Collaborators from the National Institute on Aging contributed expertise in longitudinal ageing studies, while bioinformaticians from the European Bioinformatics Institute developed the algorithms used to align sleep patterns with organ-specific methylation profiles. The study’s design, combining deep phenotyping with large-scale population data, reflects a growing trend in precision geroscience—aiming to quantify ageing as a modifiable process influenced by lifestyle factors. This institutional collaboration enabled the detection of subtle but clinically meaningful patterns that would have been obscured in smaller or less diverse cohorts.

Trade-offs in Sleep Duration and Health Outcomes

While the risks of short sleep—such as impaired cognitive function and metabolic dysregulation—are well-documented, the dangers of long sleep have been less understood, often attributed to underlying illness. This study challenges that assumption by showing that prolonged sleep duration independently accelerates biological ageing, even in individuals without diagnosed comorbidities. The trade-offs are significant: individuals sleeping less than six hours face higher risks of neurodegeneration and insulin resistance, while those exceeding nine hours show greater cardiovascular stiffening and immune senescence. However, attempting to artificially extend or restrict sleep may carry unintended consequences, as sleep need varies by genetics, age, and health status. The findings suggest that public health messaging should shift from promoting a fixed number of hours to emphasizing sleep quality and regularity, while cautioning against persistent deviations from the normative seven-hour benchmark.

Why This Discovery Emerges Now

This study arrives at a time when biological ageing metrics have matured enough to detect subtle, system-wide changes in real-world populations. Previous research was limited by reliance on single biomarkers or self-reported health outcomes, which masked organ-specific ageing trajectories. Advances in epigenetic clocks—particularly second- and third-generation models like PhenoAge and GrimAge—have enabled more accurate estimation of biological age across tissues. Additionally, the availability of large, deeply phenotyped cohorts like the UK Biobank, combined with improved computational tools for data integration, has made it possible to disentangle the complex interplay between behavior and physiological decline. The timing also reflects growing clinical interest in sleep as a modifiable risk factor for ageing-related diseases, especially as global sleep durations shift due to digitalization, urbanization, and aging populations.

Where We Go From Here

In the next 6 to 12 months, three plausible scenarios could unfold. First, clinical guidelines may begin incorporating biological age assessments into sleep disorder evaluations, particularly for middle-aged adults showing early signs of organ decline. Second, pharmaceutical and digital health companies could accelerate development of sleep-modulating interventions—ranging from cognitive behavioral therapy apps to chronotherapeutics—targeted at normalizing sleep duration. Third, public health campaigns may start emphasizing sleep as a pillar of healthy ageing, alongside diet and exercise, especially in high-income countries where sleep disruption is increasingly prevalent. Each path hinges on whether follow-up studies confirm causality and identify actionable biomarkers that can be monitored in routine care.

Bottom line — the study provides robust evidence that both short and long sleep durations accelerate biological ageing across organ systems, with implications for mental health and longevity, reinforcing sleep optimization as a critical target for preventative medicine.

Source: Nature